Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,517 $ 7,253
Restricted cash 34
Accounts receivable, net of allowance of $229 and $647 at December 31, 2023 and 2022, respectively 10,416 46,565
Inventory 4,077 18,556
Prepaid expenses and other current assets 15,125 17,289
Total current assets 37,135 89,697
Property, plant and equipment, net 4,514 7,351
Goodwill 13,641
Intangible assets, net 5,302
Right-of-use assets, net 2,648 5,697
Other non-current assets 2,975 3,407
Total assets 47,272 125,095
Current liabilities:    
Accounts payable 9,483 26,173
Accrued expenses and other current liabilities 31,981 32,243
Deferred revenue 2,700 2,892
Senior term loan 59,470 40,529
Subordinated debt 11,685 11,119
Subordinated term loan - related party 45,393 41,528
Convertible debt 33,345 43,928
Current portion of long-term debt 265 259
Total current liabilities 194,322 198,671
Other long-term liabilities 3,919 7,223
Total liabilities 198,241 205,894
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 74,638,893 and 74,283,026 shares issued and outstanding at December 31, 2023 and 2022, respectively 7 7
Additional paid-in capital 779,142 770,427
Accumulated deficit (930,118) (851,233)
Total stockholders’ deficit (150,969) (80,799)
Total liabilities and stockholders’ deficit $ 47,272 $ 125,095